Home
Products
Resources
Support
Investors
Contact
Chemistry Tools
In vitro Simulations
In vivo Simulations
Consulting Services
Databases
ADMET Predictor
ClassPharmer
DDDPlus
GastroPlus
Consulting Services
Biorelevant Solubility Database
Publications
Downloads
FAQ
Contact Support
Corporate Overview
Press Releases
Financial Info
Conference Call
Contact Investor Relations
Contact Information
Contact Form
Careers
The industry's most advanced absorption, pharmacokinetic, and pharmacodynamic simulation software package
New version 6.1!
Software for the estimation of ADMET properties combined
with advanced model-building capabilities
New metabolism and toxicity models, plus SimDOSE - a new screening capability!
Multi-purpose software for chemical data visualization and analysis
Now in 4 separate modules!
Simulation software for
in vitro
dissolution experiments
New version 3.0!
Simulations Plus Launches Biorelevant Solubility Database
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical di...
Read More
Simulations Plus Announces Renewed Share Repurchase Program
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP - News), the leading provider of simulation and modeling software for pharmace...
Read More
First Quarter FY2010 Earnings Release and Conference Call
Our CEO, Walt Woltosz, held a conference call to present our financial results for the first quarter of FY2010. To watch the presentation followed by a question and answer session,
please click here
.
Simulations Plus, Inc. 42505 10th Street West Lancaster, CA 93534-7059 USA
Phone: 661.723.7723 Fax: 661.723.5524 Email:
info@simulations-plus.com